| 000 | 01749 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514014306.0 | ||
| 264 | 0 | _c20011204 | |
| 008 | 200112s 0 0 eng d | ||
| 022 | _a0939-5555 | ||
| 024 | 7 |
_a10.1007/s002770100344 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAlessandrino, E P | |
| 245 | 0 | 0 |
_aThiotepa and fludarabine (TT-FLUDA) as conditioning regimen in poor candidates for conventional allogeneic hemopoietic stem cell transplant. _h[electronic resource] |
| 260 |
_bAnnals of hematology _cSep 2001 |
||
| 300 |
_a521-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Alkylating _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGraft Rejection _xprevention & control |
| 650 | 0 | 4 |
_aHematologic Neoplasms _xtherapy |
| 650 | 0 | 4 | _aHematopoietic Stem Cell Transplantation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aThiotepa _xadministration & dosage |
| 650 | 0 | 4 | _aTransplantation, Homologous |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVidarabine _xadministration & dosage |
| 700 | 1 | _aBernasconi, P | |
| 700 | 1 | _aColombo, A A | |
| 700 | 1 | _aCaldera, D | |
| 700 | 1 | _aBonfichi, M | |
| 700 | 1 | _aPagnucco, G | |
| 700 | 1 | _aMalcovati, L | |
| 700 | 1 | _aVarettoni, M | |
| 700 | 1 | _aLazzarino, M | |
| 700 | 1 | _aBernasconi, C | |
| 773 | 0 |
_tAnnals of hematology _gvol. 80 _gno. 9 _gp. 521-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s002770100344 _zAvailable from publisher's website |
| 999 |
_c11586654 _d11586654 |
||